A comparison between use of spray and freeze drying techniques for preparation of solid self-microemulsifying formulation of valsartan and in vitro and in vivo evaluation

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Singh, Sanjay ^a   Singh, Sanjay Kumar ^a   Vuddanda, Parameswara Rao ^a   Srivastava, Anand Kumar ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EXCIPIENT; MACROGOL 400; OCTANOIN; OIL; POLYSORBATE 80; SURFACTANT; VALSARTAN; DRUG DERIVATIVE; TETRAZOLE DERIVATIVE; VALINE; EMULSION; GAS;

ANGLE OF REPOSE; AREA UNDER THE CURVE; ARTICLE; BULK DENSITY; CHEMICAL INTERACTION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; FREEZE DRYING; FREEZE THAWING; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; LIQUID; MAXIMUM PLASMA CONCENTRATION; MEMBRANE FILTER; MICROEMULSION; PARTICLE SIZE; PLASMA CONCENTRATION-TIME CURVE; SOLID STATE; SPRAY DRYING; X RAY POWDER DIFFRACTION; ZETA POTENTIAL; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DESICCATION; EMULSION; GAS; MALE; METABOLIC CLEARANCE RATE; METHODOLOGY; ORAL DRUG ADMINISTRATION; RAT; SOLUBILITY; SPRAGUE DAWLEY RAT; SYNTHESIS; ADMINISTRATION AND DOSAGE; ANALOGS AND DERIVATIVES; PROCEDURES;

ADMINISTRATION, ORAL; ANIMALS; DESICCATION; DRUG COMPOUNDING; EMULSIONS; FREEZE DRYING; GASES; MALE; METABOLIC CLEARANCE RATE; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; TETRAZOLES; VALINE; VALSARTAN;

EID: 84881514681     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/909045     Document Type: Article

References (39)

1. Palmer A. M., New horizons in drug metabolism, pharmacokinetics and drug discovery. Drug News & Perspectives 2003 16 1 57 62 2-s2.0-0038035650 (Pubitemid 36527833)
2. Lipinski C. A., Drug-like properties and the causes of poor solubility and poor permeability. Journal of Pharmacological and Toxicological Methods 2000 44 1 235 249 2-s2.0-0034461768 10.1016/S1056-8719(00)00107-6 (Pubitemid 32239479)
3. Amidon G. L., Lennernas H., Shah V. P., Crison J. R., A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research 1995 12 3 413 420 2-s2.0-0028948839
4. Muthu M. S., Singh S., Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation. Nanomedicine 2008 3 3 305 319 2-s2.0-45149100702 10.2217/17435889.3.3.305 (Pubitemid 351827308)
5. Rawat M. K., Jain A., Singh S., Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation. Journal of Pharmaceutical Sciences 2011 100 6 2366 2378 2-s2.0-79954481926 10.1002/jps.22435
6. Yoo S. D., Lee S.-H., Kang E., Jun H., Jung J.-Y., Park J. W., Lee K.-H., Bioavailability of itraconazole in rats and rabbits after administration of tablets containing solid dispersion particles. Drug Development and Industrial Pharmacy 2000 26 1 27 34 2-s2.0-0033956224 10.1081/DDC-100100324 (Pubitemid 30075299)
7. Holm R., Müllertz A., Christensen E., Høy C.-E., Kristensen H. G., Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated triglycerides in lymph-cannulated conscious rats. European Journal of Pharmaceutical Sciences 2001 14 4 331 337 2-s2.0-0034783589 10.1016/S0928-0987(01)00186-5 (Pubitemid 33001626)
8. de Smidt P. C., Campanero M. A., Trocóniz I. F., Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: contribution of emulsification versus digestibility. International Journal of Pharmaceutics 2004 270 1-2 109 118 2-s2.0-0347022226 10.1016/j.ijpharm.2003.10. 036 (Pubitemid 38077092)
9. Pokharkar V., Kutwal M., Mandpe L., Pioglitazone solid dispersion system prepared by spray drying method: in vitro and in vivo evaluation. PDA Journal of Pharmaceutical Science and Technology 2013 67 23 34
10. Balakrishnan P., Lee B.-J., Oh D. H., Kim J. O., Lee Y.-I., Kim D.-D., Jee J.-P., Lee Y.-B., Woo J. S., Yong C. S., Choi H.-G., Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems. International Journal of Pharmaceutics 2009 374 1-2 66 72 2-s2.0-67349166936 10.1016/j.ijpharm.2009.03.008
11. Utreja P., Jain S., Yadav S., Khandhuja K. L., Tiwary A. K., Efficacy and toxicological studies of Cremophor EL free alternative paclitaxel formulation. Current Drug Safety 2011 6 5 329 338 2-s2.0-84855826196 10.2174/ 157488611798918764
12. Patel A. R., Vavia P. R., Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate. The AAPS Journal 2007 9 3 E344 E352 2-s2.0-38849151208 10.1208/aapsj0903041 (Pubitemid 351801762)
13. Atef E., Belmonte A. A., Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS). European Journal of Pharmaceutical Sciences 2008 35 4 257 263 2-s2.0-53849089890 10.1016/j.ejps.2008.07.004
14. Charman S. A., Charman W. N., Rogge M. C., Wilson T. D., Dutko F. J., Pouton C. W., Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharmaceutical Research 1992 9 1 87 93 2-s2.0-0026586447
15. Wu W., Wang Y., Que L., Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. European Journal of Pharmaceutics and Biopharmaceutics 2006 63 3 288 294 2-s2.0-33646854907 10.1016/j.ejpb.2005. 12.005 (Pubitemid 43776222)
16. Nazzal S., Khan M. A., Controlled release of a self-emulsifying formulation from a tablet dosage form: stability assessment and optimization of some processing parameters. International Journal of Pharmaceutics 2006 315 1-2 110 121 2-s2.0-33646383855 10.1016/j.ijpharm.2006.02.019 (Pubitemid 43674113)
17. Yi T., Wan J., Xu H., Yang X., A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. European Journal of Pharmaceutics and Biopharmaceutics 2008 70 2 439 444 2-s2.0-52949125231 10.1016/j.ejpb.2008.05.001
18. Wang Z., Sun J., Wang Y., Liu X., Liu Y., Fu Q., Meng P., He Z., Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. International Journal of Pharmaceutics 2010 383 1-2 1 6 2-s2.0-70449532105 10.1016/j.ijpharm.2009.08.014
19. Jannin V., Musakhanian J., Marchaud D., Approaches for the development of solid and semi-solid lipid-based formulations. Advanced Drug Delivery Reviews 2008 60 6 734 746 2-s2.0-38949117575 10.1016/j.addr.2007.09.006 (Pubitemid 351215578)
20. Tang B., Cheng G., Gu J.-C., Xu C.-H., Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms. Drug Discovery Today 2008 13 13-14 606 612 2-s2.0-45849115831 10.1016/j.drudis.2008.04.006
21. Criscione L., de Gasparo M., Buhlmayer P., Whitebread S., Ramjoue H.-P. R., Wood J., Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype. British Journal of Pharmacology 1993 110 2 761 771 2-s2.0-0027172062 (Pubitemid 23279290)
22. Dina R., Jafari M., Angiotensin II-receptor antagonists: an overview. American Journal of Health-System Pharmacy 2000 57 13 1231 1241 2-s2.0-0034235328 (Pubitemid 30441381)
23. Flesch G., Müller P., Lloyd P., Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man. European Journal of Clinical Pharmacology 1997 52 2 115 120 2-s2.0-0030979588 10.1007/s002280050259 (Pubitemid 27239595)
24. Löbenberg R., Amidon G. L., Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. European Journal of Pharmaceutics and Biopharmaceutics 2000 50 1 3 12 2-s2.0-0343527392 10.1016/S0939-6411(00)00091-6 (Pubitemid 30326685)
25. Cappello B., Di Maio C., Iervolino M., Miro A., Improvement of solubility and stability of valsartan by hydroxypropyl- β -cyclodextrin. Journal of Inclusion Phenomena 2006 54 3-4 289 294 2-s2.0-33646482724 10.1007/s10847-005- 9004-y (Pubitemid 43699981)
26. Pravin N., Babasaheb A., Neha D., Vilasrao K., Rajashree H., Solid state characterization of the inclusion complex of valsartan with methyl β -cyclodextrin. Journal of Inclusion Phenomena and Macrocyclic Chemistry 2009 65 3 377 383 2-s2.0-76749169494 10.1007/s10847-009-9595-9
27. Dixit A. R., Rajput S. J., Patel S. G., Preparation and bioavailability assessment of SMEDDS containing valsartan. AAPS PharmSciTech 2010 11 1 314 321 2-s2.0-77950917252 10.1208/s12249-010-9385-0
28. Patel D., Sawant K. K., Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS). Drug Development and Industrial Pharmacy 2007 33 12 1318 1326 2-s2.0-37549031769 10.1080/ 03639040701385527
29. Wei L., Sun P., Nie S., Pan W., Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Development and Industrial Pharmacy 2005 31 8 785 794 2-s2.0-25144440877 10.1080/03639040500216428 (Pubitemid 41356195)
30. Schaffazick S. R., Pohlmann A. R., Dalla-Costa T., Guterres S. S., Freeze-drying polymeric colloidal suspensions: nanocapsules, nanospheres and nanodispersion. A comparative study. European Journal of Pharmaceutics and Biopharmaceutics 2003 56 3 501 505 2-s2.0-0242320526 10.1016/S0939-6411(03) 00139-5 (Pubitemid 37346523)
31. Craig D. Q. M., Barker S. A., Banning D., Booth S. W., An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. International Journal of Pharmaceutics 1995 114 1 103 110 2-s2.0-0028949717 10.1016/0378-5173(94)00222-Q (Pubitemid 24377034)
32. Khoo S.-M., Humberstone A. J., Porter C. J. H., Edwards G. A., Charman W. N., Formulation design and bioavailability assessment of lipidic self- emulsifying formulations of halofantrine. International Journal of Pharmaceutics 1998 167 1-2 155 164 2-s2.0-0032103706 10.1016/S0378-5173(98)00054-4 (Pubitemid 28341517)
33. Shafiq S., Shakeel F., Talegaonkar S., Ahmad F. J., Khar R. K., Ali M., Development and bioavailability assessment of ramipril nanoemulsion formulation. European Journal of Pharmaceutics and Biopharmaceutics 2007 66 2 227 243 2-s2.0-34247609989 10.1016/j.ejpb.2006.10.014 (Pubitemid 46667230)
34. Abdullah E. C., Geldart D., The use of bulk density measurements as flowability indicators. Powder Technology 1999 102 2 151 165 2-s2.0-0345712417 10.1016/S0032-5910(98)00208-3 (Pubitemid 29195872)
35. Wormsbecker M., Pugsley T., The influence of moisture on the fluidization behaviour of porous pharmaceutical granule. Chemical Engineering Science 2008 63 16 4063 4069 2-s2.0-47849112646 10.1016/j.ces.2008.05.023
36. Singh B., Kaur T., Singh S., Correction of raw dissolution data for loss of drug and volume during sampling. Indian Journal of Pharmaceutical Sciences 1997 59 4 196 199 2-s2.0-0030819598 (Pubitemid 27414628)
37. Li D. X., Yan Y. D., Oh D. H., Yang K. Y., Seo Y. G., Kim J. O., Kim Y.-I., Yong C. S., Choi H.-G., Development of valsartan-loaded gelatin microcapsule without crystal change using hydroxypropylmethylcellulose as a stabilizer. Drug Delivery 2010 17 5 322 329 2-s2.0-77953240821 10.3109/10717541003717031
38. Pouton C. W., Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and "self-microemulsifying" drug delivery systems. European Journal of Pharmaceutical Sciences 2000 11 supplement 2 S93 S98 2-s2.0-0033805858 10.1016/S0928-0987(00)00167-6
39. Souza C. R. F., Oliveira W. P., Powder properties and system behavior during spray drying of Bauhinia forficata link extract. Drying Technology 2006 24 6 735 749 2-s2.0-33744753336 10.1080/07373930600685905 (Pubitemid 43820926)